查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969939

2026-2034年全球急性呼吸窘迫症候群（ARDS）治療設備市場規模、佔有率、趨勢及成長分析報告

Global Acute Respiratory Distress Syndrome Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 110 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

用於治療急性呼吸窘迫症候群(ARDS) 的設備的市場規模預計將從 2025 年的 4.5386 億美元成長到 2034 年的 9.2173 億美元，預計從 2026 年到 2034 年將以 8.19% 的複合年成長率成長。

受嚴重呼吸道感染疾病、肺炎、敗血症和創傷病例不斷增加的推動，全球急性呼吸窘迫症候群（ARDS）治療設備市場正穩定成長。諸如新冠肺炎（COVID-19）等大規模呼吸道感染疾病的經驗凸顯了對先進人工呼吸器、氧氣療法系統和病患監測設備的迫切需求。已開發經濟體和新興經濟體的醫院都在加大對重症監護基礎設施的投資，這大大促進了市場擴張。人們對早期呼吸介入重要性的認知不斷提高，也推動了對ARDS管理設備需求的成長。

關鍵成長要素包括機械人工呼吸器、高流量氧氣療法系統和攜帶式呼吸支援設備的技術進步。製造商正致力於提高患者舒適度、減少人工呼吸器相關併發症，並將智慧監測系統與即時數據追蹤功能結合。老年人口不斷成長，呼吸衰竭風險較高，也支撐了市場需求。此外，開發中國家醫療保健支出的增加也促進了先進重症監護設備的普及。

展望未來，由於非侵入性通氣療法和人工智慧整合監測解決方案的持續創新，ARDS設備市場預計將穩定成長。隨著各國政府加強緊急時應對計畫並擴大加加護病房（ICU），長期需求將得以維持。亞太地區和拉丁美洲醫療基礎設施的擴建可能會創造新的機會。只要呼吸系統健康仍然是全球醫療保健面臨的重大挑戰，未來前景依然樂觀。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球急性呼吸窘迫症候群（ARDS）治療設備市場：按類型分類

  • 市場分析、洞察與預測
  • 治療設備
  • 診斷和監測設備

第5章 全球急性呼吸窘迫症候群（ARDS）治療設備市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 專業醫療機構
  • 其他

第6章 全球急性呼吸窘迫症候群（ARDS）治療設備市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Koninklijke Philips NV
    • Medtronic
    • Fisher & Paykel Healthcare Limited
    • Drgerwerk AG Co KGaA
    • Smiths Medical（ICU Medical）
    • Hamilton Medical
    • GE Healthcare
    • ResMed
    • Getinge AB
簡介目錄
Product Code: VMR112110668

The Acute Respiratory Distress Syndrome Devices Market size is expected to reach USD 921.73 Million in 2034 from USD 453.86 Million (2025) growing at a CAGR of 8.19% during 2026-2034.

The Global Acute Respiratory Distress Syndrome (ARDS) Devices Market is witnessing steady growth due to the rising incidence of severe respiratory infections, pneumonia, sepsis, and trauma cases. The experience of large-scale respiratory outbreaks like COVID-19 highlighted the urgent need for advanced ventilators, oxygen therapy systems, and patient monitoring devices. Hospitals across developed and emerging economies have increased their investments in critical care infrastructure, which is significantly supporting market expansion. Growing awareness about early respiratory intervention is also contributing to higher demand for ARDS management devices.

Key growth drivers include technological advancements in mechanical ventilators, high-flow oxygen therapy systems, and portable respiratory support devices. Manufacturers are focusing on improving patient comfort, reducing ventilator-associated complications, and integrating smart monitoring systems with real-time data tracking. The rising geriatric population, which is more vulnerable to respiratory failure, further supports demand. Additionally, improved healthcare spending in developing countries is expanding access to advanced intensive care equipment.

Looking ahead, the ARDS devices market is expected to grow steadily with continuous innovation in non-invasive ventilation and AI-integrated monitoring solutions. Governments are strengthening emergency preparedness plans and upgrading ICU capacities, which will sustain long-term demand. Expansion of healthcare infrastructure in Asia-Pacific and Latin America is likely to create new opportunities. The future outlook remains positive as respiratory health continues to be a global healthcare priority.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Therapeutic Devices
  • Diagnostic & Monitoring Devices

By End-user

  • Hospitals
  • Specialty Centers
  • Others

COMPANIES PROFILED

  • Koninklijke Philips NV, Medtronic, Fisher Paykel Healthcare Limited, Drgerwerk AG Co KGaA, Smiths Medical ICU Medical, Hamilton Medical, GE Healthcare, ResMed, Getinge AB
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Therapeutic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Diagnostic & Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-user
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Specialty Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End-user
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End-user
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End-user
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End-user
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End-user
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Koninklijke Philips N.V
    • 8.2.2 Medtronic
    • 8.2.3 Fisher & Paykel Healthcare Limited
    • 8.2.4 Drgerwerk AG Co KGaA
    • 8.2.5 Smiths Medical (ICU Medical)
    • 8.2.6 Hamilton Medical
    • 8.2.7 GE Healthcare
    • 8.2.8 ResMed
    • 8.2.9 Getinge AB